The WHO's New Stance on GLP-1s: Guiding the Revolution Responsibly

A Crucial Breakthrough? Unpacking Novo Nordisk's Bold Price Slash on Wegovy in India

Beyond Blood Sugar: Unlocking a Surprising New Role for GLP-1 Drugs in Skin Health

The Battle for the Next Blockbuster: Pfizer Steps Up in the Obesity Drug Wars

Mounjaro vs. Ozempic: Unpacking the GLP-1 Showdown for Weight Loss Dominance

America's Weighty Burden: How Obesity is Crippling the U.S. Economy

WHO's Landmark Move: Adding Diabetes and Weight Loss Drugs to Essential Medicines List Sparks Hope and Debate